AI Startups
Generare raises $23.2M to discover unknown molecules and advance new drugs
Generare Bioscience SAS, a Paris-based biotechnology company generating never-before-seen molecular data for drug development using artificial intelligence, announced today it has raised €20 million, about $23.3 million, in an early-stage funding round co-led by Alven and Daphni....
S
SiliconANGLE
Source
SiliconANGLERead the full story at SiliconANGLE

AI Analysis
Generated insight by OnAirToday AI
Generare leverages AI to create novel molecular data, accelerating the identification of new drug candidates. This significant funding highlights investor confidence in AI's transformative potential within pharmaceutical research and development.
Powered by AI • Not a substitute for human analysisMore Insights →
Share
Filed under:AI Startups
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.